We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
(-8%)
Cap. Flow
-$1.7B
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$219M |
| 2 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$185M |
| 3 |
Ross Stores
ROST
|
+$144M |
| 4 |
Progressive
PGR
|
+$134M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.49B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$762M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$476M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$348M |
| 5 |
Archer Daniels Midland
ADM
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.9% |
| 2 | Industrials | 13.89% |
| 3 | Financials | 12.91% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Allegiant Air
ALGT
$2.44B
| $534K | ﹤0.01% |
3,443
+1,468
| +74% | +$248K |
|
2077
Celldex Therapeutics
CLDX
$3.42B
| $532K | ﹤0.01% |
17,424
+1,935
| +12% | +$61.9K |
|
2078
IDT Corp
IDT
$1.64B
| $532K | ﹤0.01% |
20,104
+9,407
| +88% | +$350K |
|
2079
Parsons
PSN
$5.13B
| $531K | ﹤0.01% |
14,370
-208
| -1% | -$7.09K |
|
|
DNB
2080
DELISTED
Dun & Bradstreet
DNB
| $530K | ﹤0.01% |
33,539
+4,685
| +16% | +$87.1K |
|
2081
Virtus Investment Partners
VRTS
$1.13B
| $530K | ﹤0.01% |
2,992
+1,114
| +59% | +$281K |
|
|
LBAI
2082
DELISTED
Lakeland Bancorp Inc
LBAI
| $528K | ﹤0.01% |
35,105
+15,123
| +76% | +$279K |
|
|
HOUS
2083
DELISTED
Anywhere Real Estate
HOUS
| $527K | ﹤0.01% |
48,120
+14,168
| +42% | +$237K |
|
2084
Ultragenyx Pharmaceutical
RARE
$2.62B
| $527K | ﹤0.01% |
7,459
+21
| +0.3% | +$1.46K |
|
|
HSKA
2085
DELISTED
Heska Corp
HSKA
| $525K | ﹤0.01% |
4,780
-267
| -5% | -$37.8K |
|
2086
Huron Consulting
HURN
$2.45B
| $524K | ﹤0.01% |
10,128
+3,596
| +55% | +$166K |
|
|
CTXS
2087
DELISTED
Citrix Systems Inc
CTXS
| $524K | ﹤0.01% |
5,232
-92,168
| -95% | -$9.31M |
|
2088
Opendoor
OPEN
$3.36B
| $515K | ﹤0.01% |
76,127
+15,351
| +25% | +$143K |
|
|
CERE
2089
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $512K | ﹤0.01% |
17,484
+9,596
| +122% | +$280K |
|
2090
American Airlines Group
AAL
$10.2B
| $510K | ﹤0.01% |
+27,169
| New | +$462K |
|
2091
Absci
ABSI
$1.54B
| $508K | ﹤0.01% |
60,310
-2,570
| -4% | -$20.2K |
|
2092
Strategy Inc
MSTR
$38.4B
| $508K | ﹤0.01% |
14,340
-3,930
| -22% | -$170K |
|
|
DCH
2093
Dauch Corp
DCH
$1.66B
| $507K | ﹤0.01% |
76,550
-1,739,615
| -96% | -$14.8M |
|
|
CCF
2094
DELISTED
Chase Corporation
CCF
| $507K | ﹤0.01% |
6,007
+1,335
| +29% | +$124K |
|
2095
Thryv Holdings
THRY
$94.7M
| $505K | ﹤0.01% |
19,534
+14,520
| +290% | +$455K |
|
2096
Vornado Realty Trust
VNO
$7.23B
| $503K | ﹤0.01% |
13,003
+5,433
| +72% | +$238K |
|
|
ELME
2097
Elme Communities
ELME
$145M
| $502K | ﹤0.01% |
20,844
+8,532
| +69% | +$210K |
|
2098
Griffon
GFF
$4.86B
| $501K | ﹤0.01% |
26,758
+8,203
| +44% | +$189K |
|
2099
NewMarket
NEU
$8.41B
| $499K | ﹤0.01% |
1,536
+636
| +71% | +$208K |
|
|
RAIN
2100
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $499K | ﹤0.01% |
98,480
-5,430
| -5% | -$43.5K |
|
Similar funds
VGA
Victory Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.
- Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
- Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
- Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
- Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
- Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
- Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
- Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.
Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.